II. Indications: Inflammatory Bowel Disease
- Ulcerative Colitis
- Crohns Disease (off-label use)
III. Mechanism
- 5-Aminosalicylic Acid Derivative
- Mesalamine is the active agent of the antiinflammatory Sulfasalazine
- Mesalamine decreases gastrointestinal inflammation via inhibition of cyclooxygenase and Prostaglandin
- Minimal absorption and acts locally within the bowel
IV. Dosing: Ulcerative Colitis (Adults)
- Background
- Rectal forms are preferred for Proctitis
- Use oral and rectal forms combined for better results where pancolitis is present
- Oral
- Active disease: 2.4 to 4.8 grams/day divided 1 to 3 times daily for 6 to 8 weeks (depending on agent)
- Delzicol 800 mg orally three times daily
- Pentasa 1 g orally four times daily (may be opened and mixed with water or applesauce)
- Mesalamine MMX (e.g. Lialda) 2.4 to 4.8 g orally daily with meals
- Asacol HD 1.6 g orally three times daily
- Maintenance: 1.2 to 2.4 grams/day divided 1 to 3 times daily (depending on agent)
- Delzicol 800 mg orally twice daily
- Apriso 1.5 g orally daily
- Mesalamine MMX (e.g. Lialda) 2.4 g orally daily
- Asacol HD 2.4 to 4.8 g/day orally divided three times daily
- Active disease: 2.4 to 4.8 grams/day divided 1 to 3 times daily for 6 to 8 weeks (depending on agent)
- Diazo-Bonded 5-ASA product Formulations (oral agents activated in colon)
- See Balsalazide
- See Olsalazine
- Suppository (e.g. Cantasa, for Ulcerative Proctitis)
- Active disease: 1000 mg once daily at bedtime
- Maintenance: 500 mg once to twice daily
- Enema (e.g. Rowasa 4 g in 60 ml, provides high descending colon concentrations)
- Active disease: 1 to 4 grams daily
- Maintenance: 2-4 grams daily to every third day
V. Dosing: Child
- Indicated in age 5 years and older
- Weight 17 to 32 kg
- Mesalamine 36 to 71 mg/kg/day (maximum 1.2 g/day)
- Weight 33 to 53 kg
- Mesalamine 37 to 61 mg/kg/day (maximum 2.0 g/day)
- Weight 54 to 90 kg
- Mesalamine 27 to 4 mg/kg/day (maximum 2.4 g/day)
VI. Adverse Effects
- Most common
- Other
- Interstitial Nephritis
- Hepatic failure (risk in preexisting liver disease)
- Suppositories and enemas may cause rectal irritation
- Phenylketonuria Risk (Apriso)
- Apriso contains Phenylalanine
- Digoxin
- Mesalamine may decrease levels
- Urine Color change
- Yellow-brown discolored urine
VII. Drug Interactions
- False positive Urine Metanephrines
VIII. Safety
- Pregnancy Category C
- Unknown safet in Lactation
IX. Resources
- Mesalamine Delayed Release Tablet (DailyMed)
- Mesalamine Delayed Release Capsule (DailyMed)
X. References
- Hamilton (2020) Tarascon Pocket Pharmacopoeia
- (2022) Treatment of Mild to Moderate Ulcerative Colitis, Presc Lett, #350406
- (2023) Drugs for Inflammatory Bowel Disease, Med Lett Drug Ther 65: 105-12
- Adams (2013) Am Fam Physician 87(10): 699-705 [PubMed]
- Adams (2022) Am Fam Physician 105(4): 406-11 [PubMed]
- Kornbluth (2010) Am J Gastroenterol 105(3): 501-23 [PubMed]
Images: Related links to external sites (from Bing)
Related Studies
mesalamine (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
MESALAMINE 1,000 MG SUPP | Generic | $2.21 each |
MESALAMINE 4 GM/60 ML ENEMA | Generic | $0.13 per ml |
MESALAMINE 4 GM/60 ML KIT | Generic | $116.13 each |
MESALAMINE 800 MG DR TABLET | Generic | $5.99 each |
MESALAMINE DR 1.2 GM TABLET | Generic | $2.22 each |
MESALAMINE DR 400 MG CAPSULE | Generic | $2.53 each |
MESALAMINE ER 0.375 GRAM CAP | Generic | $0.89 each |
MESALAMINE ER 500 MG CAPSULE | Generic | $4.64 each |
pentasa (on 2/23/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
PENTASA 250 MG CAPSULE | $2.91 each | |
PENTASA 500 MG CAPSULE | Generic | $4.64 each |
lialda (on 6/14/2023 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
LIALDA DR 1.2 GM TABLET | Generic | $2.05 each |
delzicol (on 7/19/2023 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
DELZICOL DR 400 MG CAPSULE | Generic | $2.11 each |